Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non–Burkitt Aggressive B-cell Lymphoma-Reference-Cited by-同舟云学术

Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non–Burkitt Aggressive B-cell Lymphoma

Published:2018-10 Issue:10 Volume:18 Page:673-678
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Cherng Hua-Jay J.,Sargent Rachel Lynn,Nasta Sunita Dwivedy,Svoboda Jakub,Schuster Stephen J.,Mato Anthony R.,Schrank-Hacker April,Morrissette Jennifer J.D.,Landsburg Daniel J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Reflecting on 25 years with MYC;Meyer;Nat Rev Cancer,2008

2. MYC, metabolism, and cancer;Stine;Cancer Discov,2015

3. Molecular diagnosis of Burkitt’s lymphoma;Dave;N Engl J Med,2006

4. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy;Savage;Blood,2009

5. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches;Petrich;Cancer,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the prognostic value of the metabolic volumetric parameters calculated with 18F-FDG PET/CT and its value added to the molecular characteristics in patients with diffuse large B-cell lymphoma;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2022-07

2. Evaluación del valor pronóstico de los parámetros volumétricos metabólicos calculados con la 18F-FDG PET/TC y su valor añadido a las características moleculares en pacientes con linfoma B difuso de células grandes;Revista Española de Medicina Nuclear e Imagen Molecular;2021-12

3. Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements;European Journal of Nuclear Medicine and Molecular Imaging;2021-09-02

4. Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model;Acta Oncologica;2021-03-15